Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
221.56
+0.47 (0.21%)
At close: Sep 23, 2026, 4:00 PM EDT
223.00
+1.44 (0.65%)
After-hours: Sep 23, 2026, 7:56 PM EDT
Danaher Revenue
Danaher had revenue of $6.27B in the quarter ending June 26, 2026, with 5.54% growth. This brings the company's revenue in the last twelve months to $25.11B, up 4.56% year-over-year. In the year 2025, Danaher had annual revenue of $24.57B with 2.90% growth.
Revenue (ttm)
$25.11B
Revenue Growth
+4.56%
P/S Ratio
6.20
Revenue / Employee
$418,450
Employees
60,000
Market Cap
155.75B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 24.57B | 693.00M | 2.90% |
| Dec 31, 2024 | 23.88B | -15.00M | -0.06% |
| Dec 31, 2023 | 23.89B | -2.75B | -10.33% |
| Dec 31, 2022 | 26.64B | 1.84B | 7.42% |
| Dec 31, 2021 | 24.80B | 2.52B | 11.30% |
| Dec 31, 2020 | 22.28B | 4.37B | 24.42% |
| Dec 31, 2019 | 17.91B | 862.00M | 5.06% |
| Dec 31, 2018 | 17.05B | 1.53B | 9.86% |
| Dec 31, 2017 | 15.52B | -1.36B | -8.08% |
| Dec 31, 2016 | 16.88B | 2.45B | 16.97% |
| Dec 31, 2015 | 14.43B | 1.57B | 12.18% |
| Dec 31, 2014 | 12.87B | -5.42B | -29.62% |
| Dec 31, 2013 | 18.28B | 22.70M | 0.12% |
| Dec 31, 2012 | 18.26B | 2.17B | 13.49% |
| Dec 31, 2011 | 16.09B | 3.54B | 28.21% |
| Dec 31, 2010 | 12.55B | 2.03B | 19.33% |
| Dec 31, 2009 | 10.52B | -2.18B | -17.17% |
| Dec 31, 2008 | 12.70B | 1.67B | 15.16% |
| Dec 31, 2007 | 11.03B | 1.56B | 16.48% |
| Dec 31, 2006 | 9.47B | 1.59B | 20.26% |
| Dec 31, 2005 | 7.87B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Thermo Fisher Scientific | 46.34B |
| IQVIA Holdings | 16.98B |
| Labcorp Holdings | 14.35B |
| Quest Diagnostics | 11.56B |
| Agilent Technologies | 7.37B |
| Waters | 4.64B |
| IDEXX Laboratories | 4.55B |
| Illumina | 4.49B |
DHR News
- 1 day ago - Danaher Schedules Third Quarter 2026 Earnings Conference Call - PRNewsWire
- 8 days ago - Danaher Announces Quarterly Dividend - PRNewsWire
- 21 days ago - Why Moderna's Cancer Vaccine Matters to Investors - ETF Trends
- 7 weeks ago - Danaher Appoints Julie Sawyer Montgomery as President and Chief Executive Officer - PRNewsWire
- 2 months ago - Don't Quit on Danaher Stock After Horrific Earnings Reaction - Barrons
- 2 months ago - Danaher's revenue outlook cut, biotech miss overshadow profit forecast raise - Reuters
- 2 months ago - Danaher Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - Danaher Quarterly report: Q2 2026 - Filings